Adicet Bio Inc.

NASDAQ: ACET · Real-Time Price · USD
0.75
0.00 (0.07%)
At close: Jun 06, 2025, 3:59 PM
0.76
1.32%
After-hours: Jun 06, 2025, 05:16 PM EDT

Adicet Bio Revenue Breakdown

Period Ending Jun 30, 2017 Jun 30, 2016 Jun 30, 2015 Jun 30, 2014 Jun 30, 2013 Jun 30, 2012
Human Health Revenue 315.39M 228.03M 225.26M 160.22M 129.67M 105.25M
Human Health Revenue Growth +38.31% +1.23% +40.60% +23.56% +23.20% n/a
Performance Chemicals Revenue 165.48M 169.48M 172.39M 173.54M 185.17M 176.14M
Performance Chemicals Revenue Growth -2.36% -1.69% -0.66% -6.28% +5.13% n/a
Pharmaceutical Ingredients Revenue 157.44M 161.01M 149.3M 176.43M 184.85M 163M
Pharmaceutical Ingredients Revenue Growth -2.21% +7.85% -15.38% -4.56% +13.41% n/a

Revenue by Geography

Period Ending Jun 30, 2017 Jun 30, 2016 Jun 30, 2015 Jun 30, 2014 Jun 30, 2013 Jun 30, 2012
United States Revenue 483.68M 34.58M 27.33M 26.16M 28.4M 25.28M
United States Revenue Growth +1298.68% +26.54% +4.47% -7.90% +12.36% n/a
Asia Pacific Revenue 29.79M 30.18M 27.98M 29.41M n/a n/a
Asia Pacific Revenue Growth -1.28% +7.87% -4.88% n/a n/a n/a
France Revenue 35.8M 76.67M 69.89M 84.02M n/a n/a
France Revenue Growth -53.31% +9.70% -16.82% n/a n/a n/a
Germany Revenue 79.11M 16.22M 14.66M 14.87M n/a n/a
Germany Revenue Growth +387.79% +10.65% -1.43% n/a n/a n/a
Netherlands Revenue 9.95M n/a n/a n/a n/a n/a
Netherlands Revenue Growth n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 7.07M 7.47M 6.9M 6.95M 5.32M 5.12M 6.63M 6.53M 6.57M 6.55M 6.42M 6.53M 6.8M 6.35M 5.21M 5.03M 5.63M 5.08M 7.74M 7.42M 2.52M 2.62M 1.85M 2.09M 2.13M -47.16M 2.27M 2.27M 2.09M -53.75M 609K 1.21M 26.52M 28.07M 21.02M 14.79M 19.5M 19.25M 17.63M 8.89M 19.07M
Selling, General, and Administrative Revenue Growth -5.34% +8.26% -0.69% +30.53% +4.01% -22.84% +1.61% -0.58% +0.24% +2.10% -1.75% -4.00% +7.07% +21.85% +3.74% -10.75% +10.91% -34.43% +4.34% +193.94% -3.77% +42.01% -11.75% -1.69% -104.51% -2180.11% -0.04% +8.31% -103.90% -8926.44% -49.50% -95.45% -5.53% +33.52% +42.18% -24.16% +1.31% +9.15% +98.37% -53.38% n/a
Research and Development Revenue 22.81M 23.27M 26.25M 25.9M 23.9M 24.76M 26.17M 28.36M 26.76M 25.02M 16.57M 16.18M 13.48M 14.66M 11.93M 10.62M 11.74M 9.68M 8.94M 8.68M 7.03M 6.52M 6.33M 5.83M 5.01M 24.18M 6.76M 11.85M 8.11M 9.95M 3.33M 2.94M 2.61M 1.34M 1.05M 1.66M 2.32M 2.53M 1.43M 2M 2.1M
Research and Development Revenue Growth -1.97% -11.35% +1.36% +8.39% -3.48% -5.38% -7.74% +6.00% +6.96% +50.97% +2.42% +19.99% -8.02% +22.91% +12.34% -9.60% +21.27% +8.29% +3.07% +23.36% +7.82% +3.03% +8.65% +16.31% -79.28% +257.40% -42.89% +46.13% -18.55% +198.59% +13.41% +12.73% +94.41% +27.71% -36.63% -28.55% -8.38% +76.99% -28.46% -4.85% n/a